CJC-1295 No DAC 5mg – Research Peptide | Tides Lab

CJC-1295 No DAC (often referred to as MOD GRF 1-29) is a synthetic analogue of growth hormone-releasing hormone (GHRH) studied in laboratory research involving pituitary signalling pathways and endocrine regulation.

Unlike CJC-1295 with Drug Affinity Complex (DAC), the no DAC variant does not bind to albumin. This shorter half-life differentiates CJC-1295 Non-DAC from CJC-1295 with DAC, which is designed for extended activity in experimental models. As a result, it exhibits a significantly shorter duration of activity in experimental models, allowing researchers to study more acute GHRH receptor signalling responses.

In research literature, CJC-1295 No DAC is commonly investigated in studies examining pulsatile growth hormone signalling and hypothalamic-pituitary regulatory mechanisms.

This 5mg lyophilised formulation is supplied at ≥99% purity and intended strictly for laboratory research purposes.

Key Features

• 5mg lyophilised CJC-1295 No DAC
• GHRH analogue studied in pituitary signalling research
• Shorter-acting variant compared to CJC-1295 DAC
• ≥99% purity
• Research use only
• Fast Australian shipping

Mechanism Overview

CJC-1295 No DAC is structurally derived from growth hormone-releasing hormone (GHRH), a peptide involved in regulating growth hormone secretion through interaction with receptors in the pituitary gland.

In laboratory research models, this peptide is described as interacting with GHRH receptors to influence downstream endocrine signalling pathways.

Because the no DAC variant lacks albumin binding, its activity window is considerably shorter than DAC-modified versions. This shorter half-life allows researchers to study transient signalling responses within pituitary and endocrine models.

These characteristics differentiate CJC-1295 No DAC from extended-release GHRH analogues used in other experimental contexts.

Stability and Handling

CJC-1295 No DAC is supplied in lyophilised (freeze-dried) form to preserve peptide stability during storage and transport.

Standard laboratory handling considerations include:

• Refrigerated storage following reconstitution
• Protection from direct light exposure
• Avoiding repeated temperature fluctuations

Maintaining cold-chain conditions is particularly important for peptide integrity during Australian shipping environments.

Research Use Only

CJC-1295 No DAC is supplied strictly for laboratory research and educational purposes. It is not approved for therapeutic use and is not intended for human consumption.